Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access information on a device and to provide personalised ads and content, ad and content measurement, audience insights and product development. List of Partners (vendors)

The first daily pill for treating endometriosis symptoms has been approved for use on the NHS in England and Wales - but only for patients who have tried all other options. Endometriosis affects 1.5 million women in the UK, causing pain and extreme tiredness as a result of tissue similar to the womb lining growing elsewhere in the body.

Hoorah for some positive women's health news! A new endometriosis pill has been made available on the NHS in England, in what's being a called a “first-of-its-kind” step forward in treating the debilitating disease.

A transformational new pill for treating endometriosis has been approved for use on the NHS across England. The new tablet, called relugolix-estradiol-norethisterone, has been approved by the drug regulator, National Institute for Health and Care Excellence (Nice).

A new pill designed to transform the treatment of endometriosis has been approved for use on the NHS. The combination drug could help around 1,000 women every year in England who suffer from the debilitating condition.

However, speaking to HuffPost UK, Hannah Travis, an associate in the medical negligence team at Bolt Burdon Kemp who focuses on women’s health, said the medication ― which is only available to people who have exhausted all other options, including surgery ― may not be as far-reaching as some may hope.

Managing debilitating symptoms for a condition that has no cure or universal treatment is almost impossible – and it's the reality for the 1.5 million women and those born female with endometriosis in the UK.